Picture of Fusen Pharmaceutical Co logo

1652 Fusen Pharmaceutical Co Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for Fusen Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line63.878.423.8-31
Depreciation
Non-Cash Items3.972640.265.6
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-68.626.4-4041.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities20.415347.8110
Capital Expenditures-200-58.6-110-29.6
Purchase of Fixed Assets
Other Investing Cash Flow Items-61-9.55-17316.4
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-261-68.2-283-13.1
Financing Cash Flow Items-0.073-9.27-0.192-17.2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5.45-11620.5-51.8
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-230-34-21647